Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function

Orr, Adam L., Kim, Chaeyoung, Jimenez-Morales, David, Newton, Billy W., Johnson, Jeffrey R., Krogan, Nevan J., Swaney, Danielle L., Mahley, Robert W.·2019·Journal of Alzheimer's Disease
DOI 10.3233/jad-181184

Cited by (103)

Items 101–103 of 103

  1. Mitochondrial genome as a therapeutic target — from evolutionary biology of the honeybee to personalized human medicine: A scoping review
    Serik D. Nurbaev · 2026 · Кубанский научный медицинский вестник
  2. Mitochondrial Complex V Dysfunction in Neurodegeneration: Secondary Bystander or Primary Driver?
    Kate Erin Harris, Gerassimos Lascaratos, Kai‐Yin Chau · 2026 · Brain Sciences
  3. Apolipoprotein E4 and immune dysfunction in Alzheimer’s disease: mechanisms and therapeutic implications
    Hao Shi, Yang Zhao, Zhu Wei, Wang Yan-jiang, Xian-Le Bu · 2026 · Trends in Neurosciences